Intuitive Surgical's new force-feedback upgrades for da Vinci 5 could spark its next adoption wave as early clinical evidence strengthens.

While the Zacks Food-Miscellaneous industry battles inflation and soft demand, SJM, LW and UNFI lean on strong brands and cost controls to drive growth.

United States Antimony Corporation is emerging as a rare U.S.-based antimony supplier, gaining strategic weight as defense and energy sectors seek secure mineral sources.

NEN incurs a Q3 net loss of $4.48 per unit as rising expenses and interest costs offset strong rental income gains driven by recent property acquisitions.

Palo Alto Networks' Q1 results are likely to reflect the benefits from the platformization strategy and rising demand for AI-driven security solutions.

Kimball Electronics (KE) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

The Beachbody Company (BODI) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Sunrise Realty Trust, Inc. (SUNS) came out with quarterly earnings of $0.31 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.25 per share a year ago.

Realty Income (NYSE: O) has declared its next monthly dividend, scheduled for payment on November 14, 2025.

Great Elm Group, Inc. ( GEG ) Q1 2026 Earnings Call November 13, 2025 8:30 AM EST Company Participants Adam Yates - Portfolio Manager Jason Reese - CEO & Executive Chairman Keri Davis - CFO & Chief Accounting Officer Presentation Operator Greetings, and welcome to the Great Elm Group Fiscal 2026 First Quarter Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.

PODD's Q3 earnings and revenues top forecasts, with strong Omnipod growth and margin expansion lifting shares.

HOLX gains expanded CE marking for its Genius Digital Diagnostics System, enabling imaging of both cell and tissue specimens on one platform.

LOS ANGELES, Nov. 13, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cytokinetics, Incorporated (“Cytokinetics” or “the Company”) (NASDAQ: CYTK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between December 27, 2023 and May 6, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before November 17, 2025.

SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Company: Avantor, Inc. (NYSE: AVTR) provides scientific products and services for customers in biotechnology, pharmaceuticals, healthcare, education, government, and other industries. Class Period: March 5, 2024 - October 28, 2025 The Case: Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Avantor common stock during the class period because the Company allegedly misled investors regarding the effects of increased competition.

Candel Therapeutics Inc (NASDAQ:CADL) reported encouraging clinical progress across its cancer immunotherapy pipeline, along with the release of its third quarter 2025 financial results. The company recently presented new Phase 3 subgroup analyses of CAN-2409 in localized prostate cancer showing statistically significant improvement in disease-free survival and updated survival data from its Phase 1b CAN-3110 trial in recurrent high-grade glioma, underscoring the potential of its multimodal immunotherapies.

Ideal Power Inc (NASDAQ:IPWR) said on Thursday it is positioning for growth in electric vehicle and data center markets after securing a development order from Stellantis for its patented B-TRAN semiconductor technology. The company said the purchase order covers custom development and packaged B-TRAN devices for multiple EV applications, with the first of five deliverables already completed and the remainder expected next year.

DG, BURL, URBN and TJX may beat Q3 estimates as value-focused pricing, e-commerce gains and inventory discipline lift retail sales and margins.